SummaryThe powerful rallies of 2013 and 2014 were driven by extreme Fed money printing to buy up bonds, and the Fed’s associated implied backstop for the stock markets.
But with QE3’s new buying terminated and any QE4 a political impossibility with the new Republican Congress, 2015 is going to look vastly different without QE.
With the Fed’s balance sheet and zeroed interest […]
On August 4th the Wall Street Journal carried a breathless tale of how a handful of obscure oilfield suppliers were striking immense riches in the sand dunes of Wisconsin. Owing to the “shale revolution”, the stock price of an outfit that had originated in the stagnating business of supplying sand traps to golf courses, and which had been at death’s door as […]
By
Robert Litan
Dow Jones Industrial Average over 2014.
The Wall Street Journal
With the stock market’s unexpected boom toward the end of 2014, what better way to ring in the new year than to reexamine that age-old question: What drives stock returns? Is it earnings’ growth fundamentals or short-term momentum swings in investor behavior?
The answer matters because most forecasters expect the economy to […]
Stocks reversed earlier gains to close lower on New Year’s Eve. Trading volume picked up a bit, but remained light. Leading stocks looked good early in the day, but once again fizzled. This has been a common theme since summer. I don’t know what it’s going to take for companies with the best growth prospects to attract investment. Wondering where […]
“Out with the old and in with the new” also applies to the stock market, although the market doesn’t always precisely follow the calendar.Healthcare stocks, which have been superior performers since 2011, lost their mojo this year, and last week they officially suffered a breakdown relative to the market. But as one season turns into the next, new sectors are […]
Market Wrap-up for Dec. 29 – The Best Performing Dividend Stocks of 2014By Tom Reese|December 29th, 2014
RSSAs the last few trading days of 2014 draw near, let’s take a look at the dividend-paying stocks that registered the biggest gains on the year.The Ground RulesBefore diving into the list, let’s first establish some ground rules for our study. Here are […]
Markets ended modestly higher on Wednesday’s abbreviated trading session banking on initial claims dropping to a seven-week low and gains in biotechs. The Dow hit a record high for the 37th session and Nasdaq also ended in the green. However, the S&P 500 erased its initial gains and a late selloff dragged the benchmark into the red.For a look at […]
by Jim Walker on Friday, December 26th, 2014 | Comments OffChristmas has come and gone and it is time to look for end of the year stock bargains. Fundamental analysis of stocks is always the key to picking up bargain stocks but where do you look and what are the important factors that will drive stock prices? Here are few […]
View gallery.It’s been a rough couple of days for biotech stocks.To start, Gilead Sciences, Inc. (NASDAQ: GILD) has dropped from a high of almost $110 per share on Friday to a low of $86 on Tuesday.Many other big-name biotechs, such as Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc (NASDAQ: BIIB) and Valeant Pharmaceuticals Intl Inc (NYSE: VRX) have fallen with […]
Wall St. inches up in short session, indexes at recordsBy Ryan VlastelicaNEW YORK Wed Dec 24, 2014 11:41am EST
Share this
Email
Print
The exterior of the New York Stock Exchange is pictured with a Christmas tree in front of it in the Manhattan Borough of New York, December 23, 2014. U.S. stocks advanced on Tuesday, as the Dow climbed above the 18,000 mark […]
